| Code | 1820D | ||||||||||
| MA number | 77/0187/19-S | ||||||||||
| Product Form: | cps dur 60x1x8 mg (blis.PVC/PVDC/Al-jednotliv.dáv.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.06.2019 |
| PIL: |
PIL_Sidarso 4 mg 8 mg cps dur_jún_2019.doc
|
| SPC: |
SPC_Sidarso 4 mg 8 mg cps dur_júl 2019.doc
|
| Safety feature | Yes |
| Data update: | 08.11.2023 |
